Biological/Vaccine — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-09-17 in 3mo
ESTIMATED |
READOUT
An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type
Phase 3 · Type 1 Diabetes, Kidney Transplant |
Vertex Pharmaceuticals Incorporate | Biological/Vaccine |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|